Frontiers in Pharmacology
Case Report: Corticosteroid-induced severe psychiatric manifestations in a patient with leptomeningeal metastases from lung adenocarcinoma
By Fan Yang, Lihong Guo, Xiangwen Xiao and 2 others.
Abstract
Background Glucocorticoids are widely used in leptomeningeal metastases (LM) to reduce peritumoral edema, yet their psychiatric adverse effects remain underrecognized, particularly progressive sensitization following long-term tolerance. Case presentation A 66-year-old male with EGFR-mutant lung adenocarcinoma and LM developed progressively worsening psychiatric manifestations after three short-course glucocorticoid exposures, despite >9 months of prior tolerance to intrathecal dexamethasone. Symptoms escalated from manic-like agitation to homicidal ideation to persecutory delusions with complete treatment refusal. A Naranjo score of 10 confirmed definite causality. Symptoms resolved after discontinuation and psychiatric hospitalization. Conclusion This case demonstrates cumulative sensitization with paradoxical dose-independent worsening of corticosteroid-induced psychiatric toxicity following long-term tolerance, whereby repeated glucocorticoid exposures produced progressively severe psychiatric reactions despite fluctuating and overall decreasing cumulative doses, supporting a “basal vulnerability plus acute trigger” model and highlighting the pivotal role of clinical pharmacists in pharmacovigilance.




